
Sign up to save your podcasts
Or


We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease.
Interview-story link:
News links:
By NEJM Group4.5
5656 ratings
We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease.
Interview-story link:
News links:

7,877 Listeners

320 Listeners

2,050 Listeners

124 Listeners

502 Listeners

298 Listeners

904 Listeners

265 Listeners

3,381 Listeners

113,519 Listeners

89 Listeners

5 Listeners

90 Listeners

520 Listeners

2,582 Listeners

367 Listeners

16,554 Listeners

59 Listeners

31 Listeners

66 Listeners